5-Fluorouracil (5-FU)
Showing 1 - 25 of >10,000
Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)
Not yet recruiting
- Gastric Cancer
- +2 more
- TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- (no location specified)
Oct 16, 2023
CIN 2/3, HIV Trial in Lilongwe (Intravaginal 5-Fluorouracil (5-FU))
Not yet recruiting
- CIN 2/3
- HIV Infections
- Intravaginal 5-Fluorouracil (5-FU)
-
Lilongwe, MalawiUNC Project, Kamuzu Central Hospital
Jan 17, 2023
Carcinoma, Squamous Cell Trial in Pittsburgh (5-fluorouracil, Imiquimod 5% cream)
Recruiting
- Carcinoma, Squamous Cell
- 5-fluorouracil
- Imiquimod 5% cream
-
Pittsburgh, PennsylvaniaSt. Margaret Hospital Dermatology
Oct 6, 2022
Basal Cell Carcinoma, BCC Trial in Aleppo (5-Fluorouracil, SURGERY)
Recruiting
- Basal Cell Carcinoma
- BCC
- 5-Fluorouracil
- SURGERY
-
Aleppo, Syrian Arab RepublicIbrahim Arnaout
Nov 28, 2023
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 19, 2022
Actinic Keratosis Trial in United States (Biopsy, Calcipotriene, Fluorouracil)
Not yet recruiting
- Actinic Keratosis
- Biopsy
- +2 more
-
Tucson, Arizona
- +3 more
Jan 25, 2023
Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,
Not yet recruiting
- Colorectal Cancer
- HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
- HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
- (no location specified)
Jul 13, 2023
Cervical Cancer, CIN2, CIN3 Trial in Westdene (5 Fluorouracil (5 FU) Cream, Placebo)
Not yet recruiting
- Cervical Cancer
- +4 more
- 5 Fluorouracil (5 FU) Cream
- Placebo
-
Westdene, Johannesburg, South AfricaClinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
Nov 30, 2022
Oral Leukoplakia Trial in San Francisco (5-fluorouracil)
Not yet recruiting
- Oral Leukoplakia
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 15, 2022
Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)
Active, not recruiting
- Oncology
- Neuroendocrine Carcinoma
- Liposomal Irinotecan
- +3 more
-
Glasgow, United Kingdom
- +3 more
Dec 2, 2022
Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,
Not yet recruiting
- Pancreatic Cancer
- +3 more
- mFOLFIRINOX
- +7 more
-
Boston, Massachusetts
- +1 more
Sep 16, 2022
First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,
Not yet recruiting
- First-line Treatment of Advanced Pancreatic Cancer
- HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
- nab-paclitaxel; gemcitabine
- (no location specified)
Feb 28, 2023
Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)
Not yet recruiting
- Metastatic Colorectal Cancer
- Hydroxychloroquine
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 24, 2023
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
Breast Cancer Trial in Oslo, Trondheim (Aromatase Inhibitor, Bevacizumab, Epirubicine)
Completed
- Breast Cancer
- Aromatase Inhibitor
- +6 more
-
Oslo, Norway
- +2 more
Jan 5, 2023
Malignant Tumor, Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Raloxifene, FOLFIRI regimen)
Recruiting
- Malignant Tumor
- Diarrhea
- Xiao Chai Hu Tang (XCHT)
- +2 more
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
Aug 11, 2022
Colorectal Cancer, Esophagus Cancer, Appendix Cancer Trial (FOX dose-escalation algorithm)
Not yet recruiting
- Colorectal Cancer
- +4 more
- FOX dose-escalation algorithm
- (no location specified)
Mar 24, 2023
Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in
Not yet recruiting
- Advanced Biliary Tract Carcinoma
- +32 more
- Biospecimen Collection
- +6 more
-
Chicago, IllinoisNorthwestern University
Feb 6, 2023
Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)
Terminated
- Colorectal Cancer
- Regorafenib
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 10, 2022
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +5 more
- Biospecimen Collection
- +9 more
-
Scottsdale, Arizona
- +2 more
Oct 11, 2023
Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,
Recruiting
- Colorectal Cancer
- +4 more
- Fosifloxuridine Nafalbenamide
- +4 more
-
Wichita, Kansas
- +5 more
Jan 9, 2023
Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium (Nanoliposomal irinotecan, 5 FU, Leucovorin)
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- Nanoliposomal irinotecan
- +3 more
-
Brugge, West-Vlaanderen, Belgium
- +11 more
Jul 25, 2022
Gastric Adenocarcinoma Trial (Pembrolizumab, Cisplatin, 5-FU)
Completed
- Gastric Adenocarcinoma
- Pembrolizumab
- +4 more
- (no location specified)
Aug 18, 2022
Stage II Colon Cancer, Stage III Colon Cancer Trial (5-Fluorouracil continuous infusion FOLFOXIRI schedule, 5-Fluorouracil bolus
Not yet recruiting
- Stage II Colon Cancer
- Stage III Colon Cancer
- 5-Fluorouracil continuous infusion FOLFOXIRI schedule
- +8 more
- (no location specified)
Aug 3, 2022